Variant report

Variant	nsv892640
Chromosome Location	chr9:16206695-16260837
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:440)
CpG islands
(count:122)
Chromatin interactive
region (count:9)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:440 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:16221777-16222097	GM12878	blood:	n/a	n/a
2	BHLHE40	chr9:16207261-16207327	GM12878	blood:	n/a	n/a
3	CEBPB	chr9:16236327-16236675	A549	lung:	n/a	n/a
4	CEBPB	chr9:16246167-16246399	HepG2	liver:	n/a	chr9:16246308-16246319
5	CEBPB	chr9:16246117-16246501	Hela-S3	cervix:	n/a	chr9:16246308-16246319
6	CEBPB	chr9:16247255-16247796	IMR90	lung:	n/a	n/a
7	CEBPB	chr9:16236289-16236673	A549	lung:	n/a	n/a
8	CEBPB	chr9:16236307-16236698	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr9:16246097-16246547	ECC-1	luminal epithelium:	n/a	chr9:16246308-16246319
10	CEBPB	chr9:16246133-16246486	A549	lung:	n/a	chr9:16246308-16246319
11	CEBPB	chr9:16236214-16236699	IMR90	lung:	n/a	n/a
12	CEBPB	chr9:16236346-16236654	HepG2	liver:	n/a	n/a
13	CEBPB	chr9:16246145-16246487	IMR90	lung:	n/a	chr9:16246308-16246319
14	CEBPB	chr9:16246071-16246523	A549	lung:	n/a	chr9:16246308-16246319
15	CEBPB	chr9:16236229-16236824	A549	lung:	n/a	n/a
16	CEBPB	chr9:16246216-16246494	ECC-1	luminal epithelium:	n/a	chr9:16246308-16246319
17	CEBPB	chr9:16246002-16246621	A549	lung:	n/a	chr9:16246308-16246319
18	CHD2	chr9:16233684-16233721	Hela-S3	cervix:	n/a	n/a
19	CTCF	chr9:16216940-16217090	HA-sp	spinal cord:	n/a	n/a
20	CTCF	chr9:16257687-16257809	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr9:16257720-16257870	GM12873	blood:	n/a	n/a
22	CTCF	chr9:16258120-16258270	HMF	breast:	n/a	n/a
23	CTCF	chr9:16257700-16257850	HAc	cerebellar:	n/a	n/a
24	CTCF	chr9:16257647-16257881	HUVEC	blood vessel:	n/a	n/a
25	CTCF	chr9:16257680-16257830	GM06990	blood:	n/a	n/a
26	CTCF	chr9:16257679-16257780	GM20000	blood:	n/a	n/a
27	CTCF	chr9:16257620-16257770	GM12874	blood:	n/a	n/a
28	CTCF	chr9:16257705-16257789	GM12892	blood:	n/a	n/a
29	CTCF	chr9:16257560-16257710	GM12866	blood:	n/a	n/a
30	CTCF	chr9:16257680-16257830	WERI-Rb-1	eye:	n/a	n/a
31	CTCF	chr9:16226872-16226945	Kidney_OC	kidney:	n/a	n/a
32	CTCF	chr9:16257680-16257830	GM12864	blood:	n/a	n/a
33	CTCF	chr9:16257335-16258124	A549	lung:	n/a	n/a
34	CTCF	chr9:16257638-16257947	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr9:16257620-16257770	GM12871	blood:	n/a	n/a
36	CTCF	chr9:16257680-16257830	GM12878	blood:	n/a	n/a
37	CTCF	chr9:16257660-16257810	AoAF	blood vessel:	n/a	n/a
38	CTCF	chr9:16257636-16257868	Hela-S3	cervix:	n/a	n/a
39	CTCF	chr9:16216960-16217110	AG04450	lung:	n/a	n/a
40	CTCF	chr9:16257736-16257791	MCF-7	breast:	n/a	n/a
41	CTCF	chr9:16257640-16257790	GM12864	blood:	n/a	n/a
42	CTCF	chr9:16257700-16257850	HRPEpiC	eye:	n/a	n/a
43	CTCF	chr9:16258180-16258330	HUVEC	blood vessel:	n/a	n/a
44	CTCF	chr9:16257720-16257870	GM12875	blood:	n/a	n/a
45	CTCF	chr9:16257960-16258110	AG04450	lung:	n/a	n/a
46	CTCF	chr9:16257680-16257830	SAEC	small airway:	n/a	n/a
47	CTCF	chr9:16257680-16257830	HepG2	liver:	n/a	n/a
48	CTCF	chr9:16257573-16257949	IMR90	lung:	n/a	n/a
49	CTCF	chr9:16257660-16257810	GM12865	blood:	n/a	n/a
50	CTCF	chr9:16257720-16257870	GM12878	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:16214627-16214677	HCPEpiC	choroid plexus:	n/a
2	chr9:16216112-16216162	HEEpiC	esophagus:	n/a
3	chr9:16216112-16216162	PrEC	prostate:	n/a
4	chr9:16216112-16216162	H1-hESC	embryonic stem cell:	embryo
5	chr9:16216112-16216162	HUVEC	blood vessel:	n/a
6	chr9:16216112-16216162	HRE	kidney:	n/a
7	chr9:16216112-16216162	ECC-1	luminal epithelium:	n/a
8	chr9:16214627-16214677	NHDF-neo	bronchial:	n/a
9	chr9:16214627-16214677	NHBE	bronchial:	n/a
10	chr9:16214627-16214677	ProgFib	skin:	n/a
11	chr9:16216112-16216162	A549	lung:	n/a
12	chr9:16214627-16214677	BJ	skin:	n/a
13	chr9:16214627-16214677	GM12891	blood:	n/a
14	chr9:16214627-16214677	HRCEpiC	kidney:	n/a
15	chr9:16214627-16214677	ovcar-3	ovarian:	n/a
16	chr9:16214627-16214677	MCF10A-Er-Src	breast:	n/a
17	chr9:16214627-16214677	BE2_C	brain:	n/a
18	chr9:16216112-16216162	HCPEpiC	choroid plexus:	n/a
19	chr9:16216112-16216162	T-47D	breast:	n/a
20	chr9:16214627-16214677	GM19239	blood:	n/a
21	chr9:16216112-16216162	MCF10A-Er-Src	breast:	n/a
22	chr9:16216112-16216162	HNPCEpiC	eye:	n/a
23	chr9:16214627-16214677	HAEpiC	amniotic membrane:	n/a
24	chr9:16214627-16214677	LNCaP	prostate:	n/a
25	chr9:16216112-16216162	SK-N-MC	brain:	n/a
26	chr9:16214627-16214677	HNPCEpiC	eye:	n/a
27	chr9:16216112-16216162	ovcar-3	ovarian:	n/a
28	chr9:16216112-16216162	HRPEpiC	eye:	n/a
29	chr9:16216112-16216162	AoSMC	blood vessel:	n/a
30	chr9:16214627-16214677	HIPEpiC	eye:	n/a
31	chr9:16216112-16216162	SK-N-SH_RA	brain:	n/a
32	chr9:16214627-16214677	AG10803	skin:	n/a
33	chr9:16216112-16216162	GM12878	blood:	n/a
34	chr9:16214627-16214677	H1-hESC	embryonic stem cell:	embryo
35	chr9:16214627-16214677	HepG2	liver:	n/a
36	chr9:16214627-16214677	HCF	heart:	n/a
37	chr9:16216112-16216162	HMEC	breast:	n/a
38	chr9:16216112-16216162	ProgFib	skin:	n/a
39	chr9:16214627-16214677	NB4	blood:	n/a
40	chr9:16214627-16214677	PrEC	prostate:	n/a
41	chr9:16216112-16216162	MCF-7	breast:	n/a
42	chr9:16214627-16214677	NT2-D1	testis:	n/a
43	chr9:16214627-16214677	HMEC	breast:	n/a
44	chr9:16214627-16214677	HRE	kidney:	n/a
45	chr9:16216112-16216162	GM12891	blood:	n/a
46	chr9:16216112-16216162	HEK293	kidney:	embryo
47	chr9:16216112-16216162	IMR90	lung:	fetal
48	chr9:16216112-16216162	BJ	skin:	n/a
49	chr9:16214627-16214677	PANC-1	pancreas:	n/a
50	chr9:16216112-16216162	U87	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:16246422..16248006-chr9:16250625..16252311,2	MCF-7	breast:
2	chr9:16246422..16248006-chr9:16250625..16252311,2	MCF-7	breast:
3	chr9:16201134..16203881-chr9:16231710..16234448,2	MCF-7	breast:
4	chr9:16259316..16262600-chr9:16264343..16266990,3	MCF-7	breast:
5	chr9:16233531..16235152-chr9:16236701..16238739,2	MCF-7	breast:
6	chr9:16207216..16210158-chr9:16217890..16219835,2	MCF-7	breast:
7	chr9:16191835..16192793-chr9:16257298..16257982,2	MCF-7	breast:
8	chr9:16233531..16235152-chr9:16236701..16238739,2	MCF-7	breast:
9	chr9:16207216..16210158-chr9:16217890..16219835,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf93-8	chr9:16216806-16219226	NONHSAT130285
2	lnc-C9orf93-7	chr9:16206806-16209226	ucscGeneNc_uc003zmh_1
3	lnc-C9orf92-1	chr9:16215214-16215277	NR_073471
4	lnc-C9orf92-1	chr9:16215770-16215897	NR_073471

No data

Variant related genes	Relation type
C9orf92	TF binding region
C9orf92	CpG island

Extended variants
information (count: 2789 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:2789 , 50 per page) page: 1 2 3 4 5 6 7 ... 56

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4961669	chr9:16206695-16206696	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs192428080	chr9:16206703-16206704	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs559195406	chr9:16206746-16206747	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs58804257	chr9:16206756-16206757	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs4961670	chr9:16206760-16206761	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs12000636	chr9:16206766-16206767	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs537099008	chr9:16206813-16206814	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
8	rs145593882	chr9:16206823-16206824	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
9	rs570539456	chr9:16206827-16206828	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs201716215	chr9:16206828-16206829	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs146697534	chr9:16206834-16206835	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs368839548	chr9:16206835-16206836	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
13	rs532897842	chr9:16206874-16206875	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs549456696	chr9:16206892-16206893	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
15	rs531116161	chr9:16206910-16206911	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
16	rs371340582	chr9:16206911-16206912	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
17	rs61674264	chr9:16206930-16206931	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
18	rs200940600	chr9:16206931-16206932	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
19	rs148830593	chr9:16206971-16206972	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
20	rs143429448	chr9:16207012-16207013	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs199933442	chr9:16207014-16207015	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs112971075	chr9:16207032-16207033	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs137953006	chr9:16207051-16207052	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs552995520	chr9:16207101-16207102	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs536137583	chr9:16207133-16207134	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs562992552	chr9:16207149-16207150	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs182764848	chr9:16207166-16207167	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs114996269	chr9:16207168-16207169	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs140541410	chr9:16207185-16207186	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs60959247	chr9:16207186-16207187	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs397734882	chr9:16207190-16207191	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs202112508	chr9:16207191-16207192	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs377543080	chr9:16207202-16207203	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs369268361	chr9:16207203-16207204	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs57130813	chr9:16207208-16207209	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs557929313	chr9:16207221-16207222	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs568627539	chr9:16207275-16207276	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs1332488	chr9:16207279-16207280	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs547692833	chr9:16207338-16207339	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs540357675	chr9:16207376-16207377	Enhancers Weak transcription Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs559107590	chr9:16207425-16207426	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs529879042	chr9:16207429-16207430	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs535490889	chr9:16207452-16207453	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs541758515	chr9:16207491-16207492	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs571020366	chr9:16207508-16207509	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs563606134	chr9:16207520-16207521	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
47	rs140878739	chr9:16207525-16207526	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
48	rs377352377	chr9:16207595-16207596	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
49	rs552168100	chr9:16207608-16207609	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
50	rs570532572	chr9:16207628-16207629	Weak transcription Enhancers Active TSS Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21611746	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:677 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16197600-16207200	Weak transcription	Ovary	ovary
2	chr9:16202000-16207200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr9:16203600-16207200	Weak transcription	Placenta Amnion	Placenta Amnion
4	chr9:16203600-16213600	Weak transcription	Rectal Smooth Muscle	rectum
5	chr9:16203800-16207000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr9:16204400-16207200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr9:16204400-16207200	Weak transcription	Fetal Lung	lung
8	chr9:16204400-16213600	Weak transcription	Colon Smooth Muscle	Colon
9	chr9:16204600-16206800	Weak transcription	HSMMtube	muscle
10	chr9:16204600-16207000	Weak transcription	Muscle Satellite Cultured Cells	--
11	chr9:16204600-16207200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr9:16204600-16207200	Weak transcription	Osteobl	bone
13	chr9:16204600-16213200	Weak transcription	NHLF	lung
14	chr9:16204600-16213600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr9:16204800-16207400	Weak transcription	HSMM	muscle
16	chr9:16205200-16207200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr9:16206000-16213600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr9:16206200-16207000	Enhancers	Primary hematopoietic stem cells	blood
19	chr9:16206200-16207000	Enhancers	Dnd41	blood
20	chr9:16206200-16207200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr9:16206200-16207400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr9:16206200-16207400	Enhancers	Fetal Kidney	kidney
23	chr9:16206400-16207000	Enhancers	Primary T cells from cord blood	blood
24	chr9:16206400-16207000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr9:16206400-16207400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr9:16206400-16207600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
27	chr9:16206400-16207800	Enhancers	Fetal Thymus	thymus
28	chr9:16206600-16207200	Enhancers	HUES64 Cell Line	embryonic stem cell
29	chr9:16206600-16207200	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr9:16206600-16207200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr9:16206600-16207400	Enhancers	H9 Cell Line	embryonic stem cell
32	chr9:16206600-16207400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr9:16206600-16207400	Enhancers	NHDF-Ad	bronchial
34	chr9:16206800-16207200	Enhancers	HSMMtube	muscle
35	chr9:16207000-16207200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
36	chr9:16207000-16207200	Enhancers	Muscle Satellite Cultured Cells	--
37	chr9:16207000-16207400	Flanking Active TSS	Primary T cells from cord blood	blood
38	chr9:16207000-16207400	Flanking Active TSS	Primary hematopoietic stem cells	blood
39	chr9:16207000-16207400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr9:16207000-16207800	Flanking Active TSS	Dnd41	blood
41	chr9:16207200-16207400	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr9:16207200-16207400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr9:16207200-16207400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
44	chr9:16207200-16207400	Enhancers	Fetal Lung	lung
45	chr9:16207200-16207400	Flanking Active TSS	Ovary	ovary
46	chr9:16207200-16207400	Enhancers	Psoas Muscle	Psoas
47	chr9:16207200-16207400	Enhancers	Right Atrium	heart
48	chr9:16207200-16207400	Enhancers	Skeletal Muscle Male	skeletal muscle
49	chr9:16207200-16207600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr9:16207200-16207600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links